Solventum Corp (SOLV): M&A transaction — Solventum completes $4.0B sale of Purification & Filtration business to Thermo Fisher

Solventum Corp

Completed sale of P&F business to Thermo Fisher for $4.0B cash on September 1, 2025.
Net proceeds of $3.4B primarily to pay down outstanding debt; accelerates debt reduction.
Updated FY2025 guidance: adjusted EPS raised to $5.88-$6.03 from $5.80-$5.95.
Net interest expense now expected at $400M (down from $450M); operating margin toward 20%-21% high-end.
Organic sales growth unchanged at +2.0% to +3.0%; free cash flow maintained at $450M-$550M.

Key facts

Extracted from this filing and checked against the source text.

M&A Transactions SEC 8-K Item 2.01/5.01 confidence 0.9

Solventum Corp completed a disposition involving Thermo Fisher Scientific Inc. for approximately $4.0 billion (closed 2025-09-01).

Action: disposition
Counterparty: Thermo Fisher Scientific Inc.
Consideration: approximately $4.0 billion
Closing: 2025-09-01

Exact text from the filing

Solventum completed the sale of the Business to the Buyer in accordance with the terms of the Agreement. The cash consideration paid to Solventum at closing was approximately $4.0 billion, which is subject to further adjustments for closing cash and indebtedness, unpaid transaction expenses and working capital as set forth in the Agreement, as well as a payment to

View on SEC.gov

Browse all m&a transactions →

Solventum Corp filing history →

Source: SEC EDGAR

accession 0001964738-25-000078

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.